期刊文献+

GATA6对先天性心脏病的影响及其突变位点的检出

The Detection of GATA6 Mutations for the CHD
原文传递
导出
摘要 GATA6属胚胎发育过程中心脏细胞的早期标志之一,是参与人类先天性心脏病发病机制中的主要候选基因之一,它对心脏发育起重要调控作用。通过对CHD患者的GATA6基因进行测序,我们发现CHD患者的GATA6基因有不同位点的突变,这些突变位点的检出有助于先天性心脏病的研究和治疗。 GATA6,a early indicator of myocardial cell development,is currently regarded as a main candidate gene of congenital heart disease(CHD). In the process of heart development,it plays a important role in the development of heart.We found out different mutations in CHD patients by suquencing the gene of GATA6 and those mutations contribute tothe study and treatment of CHD.
出处 《中国优生与遗传杂志》 2015年第4期1-2,8,共3页 Chinese Journal of Birth Health & Heredity
关键词 GATA6 突变位点 CHD GATA6 Detection of mutations
  • 相关文献

参考文献27

  • 1Liu S, Joseph KS, Lisonkova S, et al.Association between maternal chronic conditions and Congenital heart defects apopulation-based cohort study[J].Circulation, 2013, 128 (6) :583-589.
  • 2Brewer A, Pizzey J.GATA factors in vertebrate heart development and disease[J].Expert Rev Mel Med, 2006, 8 (22) ;1-20.
  • 3Horsthuis T, Christoffels VM, Anderson RH, et al.Can recent insights into cardiac development improve our understanding of congellitally malformed hearts[J].Clin Anat, 2009, 22 ( 1 ) :4-20.
  • 4Rochais F, Mesbah K, Kelly RG.signaling pathways controlling second heart field development[J].Circ Res, 2009, 104 (8) : 933-942.
  • 5Burch JB.Regulation of GATA gene expression during Vertebrate development[J].Semin Cell Dev Biol, 2005,16 ( 1 ) :71-81.
  • 6赵武(综述),李奋(审校).先天性心脏病单基因突变研究进展[J].国际儿科学杂志,2009,36(5):448-451. 被引量:4
  • 7Stoller Jz, Epstein JA.Cardiac neural crest[J].Semin Cell Dev Biol, 2005, 16 (6) :704-715.
  • 8Brown CB, Feiner L, lu MM, et al.PlexinA2 and semaphorin signaling during cardiac neural crest development[J]. Development, 2001,128 (16) :3071-3080.
  • 9Gore c, walmsley M, Nijjar S, et al.Over-expfessionof GATA-6 in Xenopus embryos blocks differentiation of heart precursofs[J]. EMBOJ, 1997, 16 (2) :355-368.
  • 10Peterkin T.Gibson A.Patient R.GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation[J]. EMBOJ, 2003,22 (16) :4260-4273.

二级参考文献65

  • 1Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet, 2001,29(4) :465-468.
  • 2Tartaglia M, Kalidas K, Shaw A, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet,2002,70(6) : 1555-1563.
  • 3Oda T, Elkahloun AG, Pike BL, et al. Mutations in the human Jaggedl gene are responsible for Alagille syndrome. Nat Genet, 1997, 16 (3):235- 242.
  • 4McElhinney DB, Krantz ID, Bason L, et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or AlagiLle syndrome. Circulation, 2002, 106 (20) : 2567- 2574.
  • 5Piacentini G, Digillo MC, Sarkozy A, et al. Genetics of congenital heart diseases in syndromic and non-syndromic patients: new advances and clinical implications. J Cardiovasc Med (Hagerstown), 2007,8 ( 1 ) : 7-11.
  • 6Schubbert S, Zenker M, Rowe SL, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet,2006,38(3):331-336.
  • 7Roberts AE,Araki T,Swanson KD,et al.Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet, 2007,39( 1 ):70-74.
  • 8Tartaglia M, Pennacchio LA, Zhao C, et al.Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet, 2007,39( 1 ) :75- 79.
  • 9Kontaridis MI, Swanson KD, David FS, et al. PIPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. J Biol Chem,2006,281 (10) :6785-6792.
  • 10McDermott DA, Bressan MC, He J, et al. TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res, 2005,58 (5) : 981-986.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部